Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial.
about
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of SchizophreniaPericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trialTreatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine.
P2860
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@en
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@nl
type
label
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@en
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@nl
prefLabel
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@en
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@nl
P2093
P2860
P50
P1476
Clinical evolution of substanc ...... pen-label, naturalistic trial.
@en
P2093
Alain Gendron
Elie Rizkallah
Jean-Pierre Chiasson
Pierre-Paul Rompré
Tania Pampoulova
P2860
P304
P356
10.1517/14656566.2010.524927
P407
P577
2010-10-28T00:00:00Z